Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 18, 2019

View Archived Issues

Corona-mediated brain targeting using short peptides for association of exchangeable apolipoproteins

Claudin-5 is a key mediator of retinal pigment epithelium pathology regulated by the circadian clock

Palbociclib prevents chemo hair loss

Inflammation stress induces red blood cell formation

Omeros presents promising phase I results for PDE7 inhibitor OMS-182399 for addiction

Enrollment ongoing in phase I study of EBV TCR-T cell therapy

Otonomy announces initiation of phase I/II study of OTO-413

Preliminary data announced from ongoing phase II study of fosmanogepix in candidemia

Treatment with luseogliflozin reverses cognitive impairments in elderly diabetes

Preliminary first-in-human data for ATA-188 support continuation of study

AMG-510 shows favorable safety profile, early promising antitumor activity in patients with NSCLC

IFN-alpha kinoid shows promise as a vaccine against type 1 diabetes in a NOD murine model

Gulp and scarf: senescent breast cancer cells eat their neighbors

Artax Biopharma presents new immunomodulators

Gilead Sciences divulges new antivirals for HBV infection

Ferro Therapeutics identifies PHGPx inhibitors

Samumed identifies new DYRK1A and/or GSK-3beta and IL-6 production inhibitors

Vitamin C-coupled compounds for cancer described in Gudui Biopharma Technology patent

FDA approves Erleada for metastatic castration-sensitive prostate cancer

Novel oxyntomodulin analogue OXM-001 reduces body weight and improves glucose tolerance

Keytruda plus Lenvima gains FDA approval for advanced endometrial carcinoma

Saniona reports phase IIa data analysis on Tesomet in adolescents with Prader-Willi syndrome

FDA clears IND for Ceraxa in AML

Antisense Therapeutics reports preliminary phase II data on ATL-1102 in Duchenne muscular dystrophy

Durect completes phase IIa trial of DUR-928 in alcoholic hepatitis

Ra's zilucoplan selected for evaluation in ALS platform trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...